Literature DB >> 26893686

Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer.

Hiroshi Kubo1, Yoshihiko Kitajima2, Keita Kai3, Jun Nakamura1, Shuusuke Miyake1, Kazuyoshi Yanagihara4, Kiyoto Morito1, Tomokazu Tanaka1, Masaaki Shida1, Hirokazu Noshiro1.   

Abstract

Solid tumors are often exposed to hypoxia. Hypoxia inducible factor (HIF)-1α upregulates numerous target genes associated with the malignant behavior of hypoxic cancer cells. A member of the angiopoietin family, angiopoietin-like protein 4 (ANGPTL4) is a hypoxia-inducible gene. The present study aimed to clarify whether ANGPTL4 is regulated by HIF-1α in gastric cancer cells. The study also assessed whether ANGPTL4 expression is associated with clinicopathological factors or HIF-1α expression in gastric cancer tissues. Hypoxia-induced ANGPTL4 expression was quantitatively analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in 10 gastric cancer cell lines. RT-qPCR was further employed to investigate the HIF-1α dependency of ANGPTL4 expression using HIF-1α-knockdown transfectant 58As9-KD and control 58As9-SC gastric cancer cells. The HIF-1α and ANGPTL4 expression levels were immunohistochemically analyzed in 170 gastric cancer tissue specimens and were assessed for any correlations with the clinicopathological factors and/or patient survival. Subsequently, hypoxia-induced ANGPTL4 expression was observed in 7 out of 10 gastric cancer cell lines. The hypoxic induction of ANGPTL4 was almost preserved in the 58As9-KD cells compared with that observed in the 58As9-SC cells, while the induction of known HIF-1α target gene, carbonic anhydrase 9, was completely suppressed in the 58As9-KD cells. In the gastric cancer tissues, ANGPTL4 expression was inversely correlated with the tumor depth, whereas HIF-1α expression was positively correlated with venous invasion. A survival analysis revealed that the expression of ANGPTL4 was significantly correlated with a longer survival time, whereas that of HIF-1α was correlated with a shorter survival time. In conclusion, the present findings indicate that hypoxia-induced ANGPTL4 expression is independent of HIF-1α in hypoxic gastric cancer cells. ANGPTL4 may be a favorable marker for predicting a long survival time, whereas HIF-1α predicts a poor prognosis, in gastric cancer patients. The hypoxic environment independently induces ANGPTL4 and HIF-1α, which are believed to exhibit adverse effects on tumor progression.

Entities:  

Keywords:  ANGPTL4; HIF-1; gastric cancer; hypoxia

Year:  2015        PMID: 26893686      PMCID: PMC4734226          DOI: 10.3892/ol.2015.4011

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  38 in total

Review 1.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.

Authors:  Gregg L Semenza
Journal:  Biochim Biophys Acta       Date:  2010-08-21

Review 2.  Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.

Authors:  Yuichi Oike; Masaki Akao; Yoshiaki Kubota; Toshio Suda
Journal:  Trends Mol Med       Date:  2005-09-08       Impact factor: 11.951

3.  Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.

Authors:  Jiadi Hu; Bruno C Jham; Tao Ma; Eitan R Friedman; Leticia Ferreira; John M Wright; Brent Accurso; Carl M Allen; John R Basile; Silvia Montaner
Journal:  Oral Oncol       Date:  2011-03-21       Impact factor: 5.337

4.  Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer.

Authors:  Yuri Akishima-Fukasawa; Yukio Ishikawa; Yoshikiyo Akasaka; Miwa Uzuki; Naomi Inomata; Tomoko Yokoo; Ryuga Ishii; Reiko Shimokawa; Kiyoshi Mukai; Hideko Kiguchi; Koyu Suzuki; Mieko Fujiwara; Kentaro Ogata; Hitoshi Niino; Hitoshi Sugiura; Akihiro Ichinose; Yoshikazu Kuroda; Daisuke Kuroda; Toshiharu Ishii
Journal:  Histopathology       Date:  2011-09       Impact factor: 5.087

5.  HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.

Authors:  Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hiraki; Hirokazu Noshiro; Kohji Miyazaki
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

6.  Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.

Authors:  Xia Lei; Fujun Shi; Debapriya Basu; Afroza Huq; Sophie Routhier; Robert Day; Weijun Jin
Journal:  J Biol Chem       Date:  2011-03-12       Impact factor: 5.157

Review 7.  Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling.

Authors:  Sergio Rey; Gregg L Semenza
Journal:  Cardiovasc Res       Date:  2010-02-17       Impact factor: 10.787

8.  Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4.

Authors:  Hongfei Ge; Guoqing Yang; Lu Huang; Daniel L Motola; Tiffany Pourbahrami; Cai Li
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

9.  Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.

Authors:  Yasuhiro Ito; Yuichi Oike; Kunio Yasunaga; Koichi Hamada; Keishi Miyata; Shun-Ichiro Matsumoto; Sumio Sugano; Hidenobu Tanihara; Yasuhiko Masuho; Toshio Suda
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

Authors:  H Zhang; C C L Wong; H Wei; D M Gilkes; P Korangath; P Chaturvedi; L Schito; J Chen; B Krishnamachary; P T Winnard; V Raman; L Zhen; W A Mitzner; S Sukumar; G L Semenza
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

View more
  8 in total

1.  Angiopoietin-like protein 2 is an important facilitator of tumor proliferation, metastasis, angiogenesis and glycolysis in osteosarcoma.

Authors:  Xiuhui Wang; Zhaohui Hu; Zhe Wang; Yin Cui; Xu Cui
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.

Authors:  T Zhang; A Kastrenopoulou; Q Larrouture; N A Athanasou; H J Knowles
Journal:  BMC Cancer       Date:  2018-05-08       Impact factor: 4.430

Review 3.  Exosome-related tumor microenvironment.

Authors:  Cheng Hu; Meijuan Chen; Rilei Jiang; Yuanyuan Guo; Mianhua Wu; Xu Zhang
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

4.  Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.

Authors:  Kotaro Ito; Yoshihiko Kitajima; Keita Kai; Shohei Matsufuji; Kohei Yamada; Noriyuki Egawa; Hiroshi Kitagawa; Keiichiro Okuyama; Tomokazu Tanaka; Hirokazu Noshiro
Journal:  Int J Oncol       Date:  2021-11-05       Impact factor: 5.650

Review 5.  Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer.

Authors:  Donghoon Kang; In-Ho Kim
Journal:  Biomedicines       Date:  2022-06-10

6.  Prognostic Significance of ANGPTL4 in Lung Adenocarcinoma: A Meta-Analysis Based on Integrated TCGA and GEO Databases.

Authors:  Yang Yang; Yufei Liu; Peiyang Gao; Ke Liu; Keni Zhao; Rongtao Ying; Jun Jiang; Xiaohong Xie; Wei Xiao; Qingsong Huang; Jianying Wu; Chuantao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-07       Impact factor: 2.650

7.  Mining the role of angiopoietin-like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis.

Authors:  Cheng Tang; Erbao Chen; Ke Peng; Haiwei Wang; Xi Cheng; Yan Wang; Shan Yu; Yiyi Yu; Yuehong Cui; Tianshu Liu
Journal:  Cancer Med       Date:  2020-05-14       Impact factor: 4.452

8.  ANGPTL4 overexpression inhibits tumor cell adhesion and migration and predicts favorable prognosis of triple-negative breast cancer.

Authors:  Yu-Chen Cai; Hang Yang; Ke-Feng Wang; Tan-Huan Chen; Wen-Qi Jiang; Yan-Xia Shi
Journal:  BMC Cancer       Date:  2020-09-14       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.